Chen, Jie
Landegger, Lukas D. http://orcid.org/0000-0002-9660-2625
Sun, Yao
Ren, Jun http://orcid.org/0000-0002-6358-0765
Maimon, Nir
Wu, Limeng
Ng, Mei R.
Chen, John W.
Zhang, Na
Zhao, Yingchao
Gao, Xing
Fujita, Takeshi
Roberge, Sylvie
Huang, Peigen http://orcid.org/0000-0002-3184-6493
Jain, Rakesh K.
Plotkin, Scott R
Stankovic, Konstantina M.
Article History
First Online: 7 January 2019
Competing interests
: R.K.J. has received consultant fees from Merck, Ophthotech, Pfizer, Sun Pharma Advanced Research Corporation (SPARC), SynDevRx, and XTuit; owns equity in Enlight, Ophthotech, SynDevRx, and XTuit; serves on the board of directors of XTuit and the boards of trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund, and Tekla World Healthcare Fund; and received honorarium for speaking at AMGEN. No funding or reagents from these companies were used in these studies. The remaining authors declare no competing interests.